STROKE: LDL and stroke risk—clinical practice or target practice?

    loading  Checking for direct PDF access through Ovid

Abstract

LDL-lowering drugs are widely recommended for the secondary prevention of vascular events in patients who have experienced a stroke or transient ischaemic attack. As a new study illustrates, however, lipid management among this group remains inadequate, possibly placing patients at unnecessary risk of stroke recurrence.

Related Topics

    loading  Loading Related Articles